CD95 (FAS/APO-1) antigen is a new prognostic marker of blast cells of acute lymphoblastic leukaemia patients.
Baryshnikov AYu, Polosukhina ER, Tupitsin NN, Gavrikova NV, Andreeva LYu, Zabotina TN, Mayakova SA, Kurmashov VI, Syrkin AB, Kadagidze ZG, Blochin DYu, Shishkin YuV.
Baryshnikov AYu, et al. Among authors: kadagidze zg.
Adv Exp Med Biol. 1999;457:251-8. doi: 10.1007/978-1-4615-4811-9_27.
Adv Exp Med Biol. 1999.
PMID: 10500800
Clinical Trial.